Functional chimeric mRNAs encode proteins in mammalian immunity

Functional chimeric mRNAs encode proteins in mammalian immunity Researchers have discovered that functional chimeric mRNAs, molecules formed by the fusion of genetic material from different genes, can produce proteins in healthy mammalian cells, challenging previous assumptions about how cellular protein diversity is generated. These findings, based on experiments conducted on mouse bone-marrow-derived macrophages, suggest that such chimeric RNAs might play a role in immune responses and could represent a previously underappreciated layer of genetic complexity in mammalian biology. The study focused on identifying chimeric RNAs (chRNAs) in mice, particularly in macrophages, which are key players in the immune system. To avoid the biases introduced by traditional RNA sequencing methods, researchers employed Oxford Nanopore PromethION technology to perform direct RNA sequencing on polyadenylated RNA extracted from three types of mouse macrophages: those in a steady state, those engaged in tissue repair, and those responding to inflammation. A total of ten biological replicates were analyzed, generating approximately 52.9 million passing reads. Over 90% of these reads successfully mapped to the mouse genome, indicating a high degree of accuracy and reliability in the data. The results revealed the presence of more than 30,000 exon-exon chRNAs. These chRNAs were found to originate from distinct genes and exhibited varying levels of expression depending on the type of macrophage studied. Notably, the highest abundance of chRNAs was observed in inflamed macrophages, suggesting a potential link between inflammation and the generation of these molecular hybrids. This finding aligns with earlier observations in simpler organisms like trypanosomes and nematodes, where trans-splicing, a process involving the joining of exons from separate pre-mRNAs, was shown to contribute to transcript stability and functional diversity. While chRNAs have historically been associated with cancerous transformations, where genomic rearrangements lead to the fusion of unrelated genes, this new research indicates that such structures may also emerge in normal tissues. The study highlights that many chRNAs previously thought to result from DNA-level translocations might instead arise through trans-splicing, a mechanism that allows for the creation of novel protein-coding sequences without altering the underlying genome. A major challenge in detecting chRNAs lies in the limitations of current sequencing technologies. Traditional RNA-seq methods often fail to capture these molecules due to issues such as template-switching artifacts during cDNA synthesis and the lack of annotation for chRNAs in existing reference transcriptomes. As a result, many putative chRNAs identified in previous studies may have been dismissed as experimental noise rather than genuine biological phenomena. The use of long-read sequencing, however, enabled the researchers to overcome these obstacles and reliably detect chRNAs in healthy tissue. The implications of this work extend beyond basic science. If chRNAs indeed contribute to the functional diversity of proteins in mammalian cells, they could offer new avenues for understanding immune regulation and disease pathogenesis. Further research will be needed to determine the extent to which these chRNAs influence cellular processes and whether they can be harnessed therapeutically. For now, the study represents a critical step toward unraveling the complex mechanisms that govern protein production in mammalian systems.